… Our data suggest that inhaled antibiotics consistently achieve reductions in bacterial load
and bacterial eradication, but this translates into a small—although significant—effect on …

… of antibiotics have been approved for inhaled … meta-analysis of the use adjunctive inhaled
antibiotics were conducted. A comparison between the use of adjunctive inhaled antibiotics …

… were included in this meta-analysis. Long-term inhaled antibiotics showed an obvious reduction
… aeruginosa resistance after inhaled therapy. In addition, nebulized therapy reduced the …

… with 2748 patients were included in this meta-analysis. Patients received inhaled therapy
with either antibiotics or placebo. The treatment course ranged from 4 weeks to 52 weeks. …

… , use of inhaled antibiotics in patients with non-CF bronchiectasis needs to be addressed. …
and meta-analysis of randomised trials to assess the efficacy and safety of inhaled antibiotics …

… Levofloxacin inhalation solution (LIS) is the most recently approved inhaled antibiotic for
adult patients with CF. A systematic literature review and Bayesian network meta-analysis (NMA…

Background Inhaled antibiotics (IA) in non-cystic fibrosis bronchiectasis (NCFB) are
recommended by some clinical practice guidelines for prevention or treatment of NCFB …

… is how best to implement multiple inhaled antibiotics in the clinical setting. Based on the
original studies of tobramycin solution for inhalation, inhaled antibiotics have been cycled every …

… compared with intravenous antibiotics [5, 6]. However, the role of aerosolized antibiotics in
… VAP or VAT, the efficacy and safety of using inhaled antibiotics for treatment of VAP or VAT. …

… meta-analysis (NMA) is to evaluate effectiveness and safety of inhaled antibiotics administered
via dry powder inhaler … years) with NCFB, and inhaled antibiotics administered via DPI as …